Asensus Surgical, Inc. (ASXC)
| Market Cap | 460.53M |
| Revenue (ttm) | 3.18M |
| Net Income (ttm) | -60.02M |
| Shares Out | 70.81M |
| EPS (ttm) | -0.85 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 21 |
| Last Price | $1.98 |
| Previous Close | $1.52 |
| Change ($) | 0.46 |
| Change (%) | 30.26% |
| Day's Open | 1.43 |
| Day's Range | 1.38 - 2.07 |
| Day's Volume | 22,534,887 |
| 52-Week Range | 0.30 - 6.95 |
Today, investors in ASXC stock are seeing some very nice gains as optimism grows in the surgical sector coming out of this pandemic. The post ASXC Stock: Why Penny Stocks Play Asensus Surgical Is Soarin...
Once flying high on their status as Reddit stocks, these nine penny stocks are falling back towards prior price levels. The post 9 Reddit Penny Stocks That Are Running Out of Gas appeared first on Inves...
Investors need to pay close attention to Asensus (ASXC) stock based on the movements in the options market lately.
ASXC stock rode the Reddit rally up. Now the business has to deliver — but there's simply not enough evidence to bet on that happening.
Investors may be well-served by having a look at this company's financials before buying TRXC stock. The post Asensus Surgical's Name Has Changed, But Investors' Valuation Concerns Haven't appeared firs...
ASXC stock is extremely overvalued. And that means that investors may be waiting a long time for the stock to meet its lofty expectations.
With the jury still out whether its Sehance digital-surgery system is finally ready for primetime, there's no use buying into ASXC stock at today's inflated price. The post Despite Name Change, Asensus ...
Before you consider investing in ASXC stock, you'll definitely want to be aware of the important changes going on in the stock and company. The post In a Time of Transition, Asensus Surgical Stock Remai...
TRXC stock has undergone a name change but that doesn't change the nature of the investment, for better or for worse. The post Transenterix Stock Has More Problems Than a Simple Name Change Can Fix appe...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...
TransEnterix is now Asensus Surgical. However, this is unlikely to improve sales for Asensus' floundering line of products.
Whether you're looking to invest in TRXC stock or its successor, Asensus Surgical, you'll need something to handle the volatility. The post TransEnterix or Asensus Surgical?
TransEnterix (TRXC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Asensus and TRXC stock has gotten a $1 billion market cap on introducing Senhance, a robotic surgery system for abdominal surgery. Knowing whether it will succeed will take time.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon a...
Shares of TRXC stock are rising on Wednesday after the firm received general surgery clearance from the FDA for its Senhance Surgical System. The post TRXC Stock: Why Medical Device Play Asensus Surgica...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon ...
TRXC stock is a better option than many “meme” stocks that retail investors have bid higher. It's a reminder that a little bit of homework can go a long way.
TransEnterix (TRXC) closed at $3.72 in the latest trading session, marking no change from the prior day.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon a...
Shares of the robotic surgical-system manufacturer are soaring, but can this company become the next Intuitive Surgical?
TRXC stock has pulled off a nice rally. But the company's systems could take some time to get traction.
TRXC stock could become the next Intuitive Surgical. The company is funded, and has to simply develop its business now.
TransEnterix announced a company renaming amid a broad selloff that had TRXC stock down more than 15% in trading today. The post TRXC Stock: What to Know as Red-Hot TransEnterix Falls 17% Today appeared...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally...
TRXC stock has struggled badly since its 2014 IPO. A trader-driven rally is unlikely to change the concerning long-term trend.
As TRXC stock takes a breather amid a sustained uptrend, investors should consider owning shares of this medical robotics innovator. The post Make a Surgical Strike With TransEnterix Stock appeared firs...
With its ultra-low price point and the relevant business of minimally invasive surgeries, TRXC stock has garnered much attention. Still, prospective buyers should look at the broader context before divi...
Is (TRXC) Outperforming Other Medical Stocks This Year?
TRXC stock has potential to become the next Intuitive Surgical with its Senhance platform opening up a multi-billion dollar revenue stream The post TransEnterix Has A Compelling Case To Be The Next Intu...
Does TransEnterix (TRXC) have what it takes to be a top stock pick for momentum investors? Let's find out.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally...
TransEnterix is facing competition from a number of much larger companies, while its revenue is quite low. Investors should take profits on TRXC stock.
So, after contrasting the opportunities and risks with TRXC stock, what's the play? It may be interesting at lower prices.
TransEnterix is currently trading above $5. But does TRXC stock have what it takes to be the next Intuitive Surgical?
TransEnterix stock is up in trading today after a pair of big stock sales and ahead of its Feb. 23 Investor Day. The post TRXC Stock: Why TransEnterix Shares Are Soaring Today appeared first on Investor...
TRXC stock will do well over time, now that the company is well-capitalized. But does that mean it's a good time for new investors to hop on?
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally...
One robotic surgery company and one cybersecurity specialist are bound to impress in the long run.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally...
Surgical robotics is a fascinating market niche with huge potential, and you can capitalize on its expansion with a position in TRXC stock. The post Hold TransEnterix Stock as This Tiny Company Has Big ...
Could there be more gains ahead for these recovering companies?
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon a...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon a...
Does TransEnterix (TRXC) have what it takes to be a top stock pick for momentum investors? Let's find out.
TransEnterix (TRXC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The robotic surgery specialist is helping to enhance the capabilities of surgeons, but its shares may have come too far, too fast.
TransEnterix (TRXC) is seeing shares of TRXC stock soar higher on Tuesday following an update concerning its Intelligent Surgical Unit. The post TRXC Stock: 5 Things to Know About Surgical Robotics Play...
About ASXC
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to fou... [Read more...]
| Industry Medical Devices | Founded 2006 |
| CEO Anthony Fernando | Employees 128 |
| Stock Exchange NYSEAMERICAN | Ticker Symbol ASXC |
Financial Performance
In 2020, ASXC's revenue was $3.18 million, a decrease of -62.78% compared to the previous year's $8.53 million. Losses were -$59.31 million, -61.54% less than in 2019.
Analyst Forecasts
The average 12-month stock price forecast for ASXC is 1.45, which is a decrease of -26.77% from the latest price.